FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19

UPDATED: FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 Emergency In response to the Novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing updates to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients. Read More